Hinge Bio Funding & Investors
Burlingame, CA
Hinge Bio is a biotechnology company that specializes in leveraging its proprietary Flex-Hinge antibody platform to develop bispecific and multispecific antibodies. It features chemical ligation process technology that enables the production of therapeutic candidates with orders-of-magnitude improved affinity and specificity. The company was founded in 2015 and headquartered in Burlingame, California.
hingebio.comTotal Amount Raised: $30,224,456
Hinge Bio Funding Rounds
Series A
$30,000,000
Series A Investors
Point72InVivium CapitalLightswitch CapitalGrant
$224,455
Grant Investors
National Science Foundation (NSF)
Funding info provided by Diffbot.